Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Re-emergence of Corynebacterium diphtheriae.

Scheifer C, Rolland-Debord C, Badell E, Reibel F, Aubry A, Perignon A, Patey O, Brisse S, Caumes E.

Med Mal Infect. 2018 Dec 21. pii: S0399-077X(17)30962-9. doi: 10.1016/j.medmal.2018.12.001. [Epub ahead of print]

PMID:
30583866
2.

Taxonomic status of Corynebacterium diphtheriae biovar Belfanti and proposal of Corynebacterium belfantii sp. nov.

Dazas M, Badell E, Carmi-Leroy A, Criscuolo A, Brisse S.

Int J Syst Evol Microbiol. 2018 Dec;68(12):3826-3831. doi: 10.1099/ijsem.0.003069. Epub 2018 Oct 24.

PMID:
30355399
3.

Diphtheria in Mayotte, 2007-2015.

Belchior E, Henry S, Badell E, Collet L, Benoit-Cattin T, de Montera AM, Guiso N, Patey O, Levy-Bruhl D, Filleul L, Chieze F, Olivier S.

Emerg Infect Dis. 2017 Jul;23(7):1218-1220. doi: 10.3201/eid2307.170262.

4.

Microbiological and molecular characterization of Corynebacterium diphtheriae isolated in Algeria between 1992 and 2015.

Benamrouche N, Hasnaoui S, Badell E, Guettou B, Lazri M, Guiso N, Rahal K.

Clin Microbiol Infect. 2016 Dec;22(12):1005.e1-1005.e7. doi: 10.1016/j.cmi.2016.08.013. Epub 2016 Aug 29.

5.

Draft Genome Sequence of Toxigenic Corynebacterium ulcerans Strain 03-8664 Isolated from a Human Throat.

Guimarães LC, Viana MV, Benevides LJ, Mariano DC, Veras AA, Sá PH, Rocha FS, Vilas Boas PC, Soares SC, Barbosa MS, Guiso N, Badell E, Azevedo V, Ramos RT, Silva A.

Genome Announc. 2016 Jul 28;4(4). pii: e00719-16. doi: 10.1128/genomeA.00719-16.

6.

Draft Genome Sequence of Toxigenic Corynebacterium ulcerans Strain 04-7514, Isolated from a Dog in France.

Guimarães LC, Viana MV, Benevides LJ, Mariano DC, Veras AA, Sá PH, Rocha FS, Vilas Boas PC, Soares SC, Barbosa MS, Guiso N, Badell E, Carneiro AR, Azevedo V, Ramos RT, Silva A.

Genome Announc. 2016 Mar 31;4(2). pii: e00172-16. doi: 10.1128/genomeA.00172-16.

7.

Draft Genome Sequence of Corynebacterium ulcerans Strain 04-3911, Isolated from Humans.

Guimarães LC, Viana MV, Benevides LJ, Mariano DC, Veras AA, Sá PH, Rocha FS, Vilas Boas PC, Soares SC, Barbosa MS, Guiso N, Badell E, Carneiro AR, Azevedo V, Ramos RT, Silva A.

Genome Announc. 2016 Mar 31;4(2). pii: e00171-16. doi: 10.1128/genomeA.00171-16.

8.

Draft Genome Sequences of Two Pathogenic Corynebacterial Species Isolated from Cows.

Guimarães LC, Lopes T, Ramos RT, Carneiro AR, Cavalcante AL, Barreto D, de Sá PC, Veras AA, Rocha FS, Bagano P, Pereira FL, Dorella FA, Leal CA, Carvalho AF, Bizet C, Guiso N, Badell E, Figueiredo HC, Azevedo V, Silva A.

J Genomics. 2016 Mar 2;4:7-9. doi: 10.7150/jgen.14456. eCollection 2016.

9.

[Corynebacterium ulcerans pulmonary infection].

Thouvenin M, Beilouny B, Badell E, Guiso N.

Ann Biol Clin (Paris). 2016 Jan-Feb;74(1):117-20. doi: 10.1684/abc.2015.1120. French.

10.

[Whole cell protein profiling characterization of Corynebacterium diphtheriae clinical isolates collected from various infections].

Zasada AA, Rzeczkowska M, Wołkowicz T, Formińska K, Zacharczuk K, Wolaniuk N, Paduch O, Badell E, Januszkiewicz A, Guiso N.

Med Dosw Mikrobiol. 2016;68(3-4):161-166. Polish.

PMID:
30376615
11.

Toxigenic Corynebacterium ulcerans in a fatal human case and her feline contacts, France, March 2014.

Vandentorren S, Guiso N, Badell E, Boisrenoult P, Micaelo M, Troché G, Lecouls P, Moquet MJ, Patey O, Belchior E.

Euro Surveill. 2014 Sep 25;19(38). pii: 20910.

12.

Photo quiz: multiple skin lesions on a 9-year-old boy returning from Mali.

Farfour E, Badell E, Jacques Natali L, Dommergues MA, Blot S, Guiso N, Pangon B, Foucaud P.

J Clin Microbiol. 2014 Oct;52(10):3523; discussion 3832-3. doi: 10.1128/JCM.00779-13. No abstract available.

13.

The utility of the PCR melting profile technique for typing Corynebacterium diphtheriae isolates.

Zasada AA, Formińska K, Wołkowicz T, Badell E, Guiso N.

Lett Appl Microbiol. 2014 Sep;59(3):292-8. doi: 10.1111/lam.12274. Epub 2014 May 5.

14.

Draft Genome Sequence of Corynebacterium ulcerans FRC58, Isolated from the Bronchitic Aspiration of a Patient in France.

Silva Ado S, Baraúna RA, de Sá PC, das Graças DA, Carneiro AR, Thouvenin M, Azevedo V, Badell E, Guiso N, da Silva AL, Ramos RT.

Genome Announc. 2014 Jan 9;2(1). pii: e01132-13. doi: 10.1128/genomeA.01132-13.

15.

New diphtheria toxin repressor types depicted in a Romanian collection of Corynebacterium diphtheriae isolates.

Dinu S, Damian M, Badell E, Dragomirescu CC, Guiso N.

J Basic Microbiol. 2014 Oct;54(10):1136-9. doi: 10.1002/jobm.201300686. Epub 2013 Dec 2.

PMID:
24293345
16.

Microbiological changes and diversity in autochthonous non-toxigenic Corynebacterium diphtheriae isolated in France.

Farfour E, Badell E, Dinu S, Guillot S, Guiso N.

Clin Microbiol Infect. 2013 Oct;19(10):980-7. doi: 10.1111/1469-0691.12103. Epub 2013 Jan 15.

17.

Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli.

Farfour E, Leto J, Barritault M, Barberis C, Meyer J, Dauphin B, Le Guern AS, Leflèche A, Badell E, Guiso N, Leclercq A, Le Monnier A, Lecuit M, Rodriguez-Nava V, Bergeron E, Raymond J, Vimont S, Bille E, Carbonnelle E, Guet-Revillet H, Lécuyer H, Beretti JL, Vay C, Berche P, Ferroni A, Nassif X, Join-Lambert O.

J Clin Microbiol. 2012 Aug;50(8):2702-7. doi: 10.1128/JCM.00368-12. Epub 2012 Jun 12.

18.

Antimicrobial drug resistance in Corynebacterium diphtheriae mitis.

Barraud O, Badell E, Denis F, Guiso N, Ploy MC.

Emerg Infect Dis. 2011 Nov;17(11):2078-80. doi: 10.3201/eid1711.110282. No abstract available.

19.

Characterization and comparison of invasive Corynebacterium diphtheriae isolates from France and Poland.

Farfour E, Badell E, Zasada A, Hotzel H, Tomaso H, Guillot S, Guiso N.

J Clin Microbiol. 2012 Jan;50(1):173-5. doi: 10.1128/JCM.05811-11. Epub 2011 Nov 16.

20.

Diphtheria in the south of France, March 2011.

Rousseau C, Belchior E, Broche B, Badell E, Guiso N, Laharie I, Patey O, Levy-Bruhl D.

Euro Surveill. 2011 May 12;16(19). pii: 19867.

21.

Multilocus sequence typing identifies evidence for recombination and two distinct lineages of Corynebacterium diphtheriae.

Bolt F, Cassiday P, Tondella ML, Dezoysa A, Efstratiou A, Sing A, Zasada A, Bernard K, Guiso N, Badell E, Rosso ML, Baldwin A, Dowson C.

J Clin Microbiol. 2010 Nov;48(11):4177-85. doi: 10.1128/JCM.00274-10. Epub 2010 Sep 15.

22.

Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination.

Clark SO, Kelly DL, Badell E, Castello-Branco LR, Aldwell F, Winter N, Lewis DJ, Marsh PD.

Vaccine. 2010 Oct 8;28(43):7109-16. doi: 10.1016/j.vaccine.2010.07.087. Epub 2010 Aug 12.

PMID:
20708695
23.

Mycobacterium bovis bacillus Calmette-Guérin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production.

Martino A, Badell E, Abadie V, Balloy V, Chignard M, Mistou MY, Combadière B, Combadière C, Winter N.

J Immunol. 2010 Feb 15;184(4):2038-47. doi: 10.4049/jimmunol.0903348. Epub 2010 Jan 18.

24.

A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis.

Tanne A, Ma B, Boudou F, Tailleux L, Botella H, Badell E, Levillain F, Taylor ME, Drickamer K, Nigou J, Dobos KM, Puzo G, Vestweber D, Wild MK, Marcinko M, Sobieszczuk P, Stewart L, Lebus D, Gicquel B, Neyrolles O.

J Exp Med. 2009 Sep 28;206(10):2205-20. doi: 10.1084/jem.20090188. Epub 2009 Sep 21.

25.

TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans.

Chassin C, Picardeau M, Goujon JM, Bourhy P, Quellard N, Darche S, Badell E, d'Andon MF, Winter N, Lacroix-Lamandé S, Buzoni-Gatel D, Vandewalle A, Werts C.

J Immunol. 2009 Aug 15;183(4):2669-77. doi: 10.4049/jimmunol.0900506. Epub 2009 Jul 27.

26.

Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.

Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.

Vaccine. 2009 Jan 1;27(1):28-37. doi: 10.1016/j.vaccine.2008.10.034. Epub 2008 Oct 31.

PMID:
18977269
27.

Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice.

Morel C, Badell E, Abadie V, Robledo M, Setterblad N, Gluckman JC, Gicquel B, Boudaly S, Winter N.

Eur J Immunol. 2008 Feb;38(2):437-47. doi: 10.1002/eji.200737905.

28.

T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals.

Martinez V, Carcelain G, Badell E, Jouan M, Mauger I, Sellier P, Truffot C, Bricaire F, Arend SM, Ottenhoff T, Autran B, Gicquel B.

BMC Infect Dis. 2007 Jul 26;7:83.

29.

Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes.

Abadie V, Badell E, Douillard P, Ensergueix D, Leenen PJ, Tanguy M, Fiette L, Saeland S, Gicquel B, Winter N.

Blood. 2005 Sep 1;106(5):1843-50. Epub 2005 May 10.

30.

Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function.

Kissenpfennig A, Aït-Yahia S, Clair-Moninot V, Stössel H, Badell E, Bordat Y, Pooley JL, Lang T, Prina E, Coste I, Gresser O, Renno T, Winter N, Milon G, Shortman K, Romani N, Lebecque S, Malissen B, Saeland S, Douillard P.

Mol Cell Biol. 2005 Jan;25(1):88-99.

31.

Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.

Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro G, Zakin MM, Scott-Algara D.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):756-61. Epub 2004 Jan 29.

PMID:
14751811
32.
33.

Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses.

Méderlé I, Bourguin I, Ensergueix D, Badell E, Moniz-Peireira J, Gicquel B, Winter N.

Infect Immun. 2002 Jan;70(1):303-14.

34.

CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART.

Scott-Algara D, Aboulker JP, Durier C, Badell E, Marcellin F, Prud'homme M, Jouanne C, Meiffredy V, Brun-Vezinet F, Pialoux G, Raffi F; ANRS-072 Trial Group.

Clin Exp Immunol. 2001 Nov;126(2):295-303.

35.

Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Moreno A, Badell E, Van Rooijen N, Druilhe P.

Antimicrob Agents Chemother. 2001 Jun;45(6):1847-53.

36.

Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.

Brahimi K, Badell E, Sauzet JP, BenMohamed L, Daubersies P, Guérin-Marchand C, Snounou G, Druilhe P.

Infect Immun. 2001 Jun;69(6):3845-52.

37.

Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum.

Badell E, Oeuvray C, Moreno A, Soe S, van Rooijen N, Bouzidi A, Druilhe P.

J Exp Med. 2000 Dec 4;192(11):1653-60.

38.

Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen.

Fidock DA, Pasquetto V, Gras H, Badell E, Eling W, Ballou WR, Belghiti J, Tartar A, Druilhe P.

Eur J Immunol. 1997 Oct;27(10):2502-13. Erratum in: Eur J Immunol 1997 Nov;27(11):3084.

PMID:
9368603
39.

Human Plasmodium liver stages in SCID mice: a feasible model?

Badell E, Pasquetto V, Eling W, Thomas A, Druilhe P.

Parasitol Today. 1995 May;11(5):169-71.

PMID:
15275348
40.

Lack of antibodies to HIV in Pemon Indians in Venezuela.

Hernandez Rivero C, Badell E, Robinson JE, Carlton CG, Sorensen RU.

AIDS. 1992 Feb;6(2):231. No abstract available.

PMID:
1558721
41.

Determination of phagocytosis of Leishmania spp. by human polymorphonuclear leukocytes using anti-Leishmania monoclonal antibodies.

Infante RB, Pérez M, Di Prisco-Fuenmayor MC, Badell E, Lynch NR.

J Investig Allergol Clin Immunol. 1991 Jun;1(3):209-12.

PMID:
1727010

Supplemental Content

Loading ...
Support Center